SCHEMBL33377931

SCHEMBL33377931

CC(C)c1cnn2c(NCCc3ccccn3)cc(Cl)nc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.45
▸ MAPT P10636 5/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ CDK7 P50613 9/20 0.43
▸ CDK2 P24941 5/20 0.43
▸ CCNE1 P24864 4/20 0.43
▸ CCNH P51946 4/20 0.43
▸ CDK1 P06493 3/20 0.43
▸ MNAT1 P51948 3/20 0.43
▸ CCNT1 O60563 2/20 0.43
▸ CDK4 P11802 2/20 0.43
▸ CCNB1 P14635 2/20 0.43
▸ CCND1 P24385 2/20 0.43
▸ CDK8 P49336 2/20 0.43
▸ CDK9 P50750 2/20 0.43
▸ CDK6 Q00534 2/20 0.43
▸ CDK5 Q00535 2/20 0.43
▸ CDK5R1 Q15078 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33378025 0.89 KDM4E (0.56) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL33378036 0.85 CDK7 (0.60) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL33378040 0.84 CDK7 (0.48) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL33378034 0.83 CDK2 (0.46) KDM4EMAPTKMT2ACDK7CDK2
SCHEMBL33377864 0.82 CDK7 (0.50) CDK7CDK2CCNE1CCNHCDK1
SCHEMBL33378024 0.81 GSK3B (0.49) CDK7CDK2CCNE1CCNHCDK1
SCHEMBL33377947 0.80 KDM4E (0.42) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL33377988 0.79 CDK2 (0.42) KMT2ACDK7CDK2CCNE1CCNH
SCHEMBL1370667 0.78 CDK7 (0.66) NPC1RAB9AKMT2ACDK7CDK2
SCHEMBL33378043 0.78 CDK7 (0.46) KDM4EMAPTNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback